Insights on the Polymer Modified Cementitious Coatings Global Market to 2027 - Featuring Akzo Nobel, Arkema and Berger Paints India Among Others - ResearchAndMarkets.com
Amid the COVID-19 crisis, the global market for Polymer Modified Cementitious Coatings estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 5.3% over the period 2020-2027.
Flexible, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Flexible segment is readjusted to a revised 4.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $289.4 Million, While China is Forecast to Grow at 8.2% CAGR
The Polymer Modified Cementitious Coatings market in the U.S. is estimated at US$289.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$321.5 Million by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024.
Highlights for the Quarter:
Net income available to common...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...